Speaker Antonio Toesca2019-05-29T10:45:20+08:00

Keynote Speakers

Dr. Toesca is a surgeon who specializes in the treatment of breast cancer.

He is Internationally recognized for his work for the advancement of breast cancer management and renowned for his innovative ideas in precise and individualized medicine, oncoplastic mini-invasive breast cancer treatments, scientific communication and educational development.

He is in charge as full member at European Institute of Oncology in Milan.

Since 2014 he is team leader consultant of Robotic Mini-invasive Mastectomy and Reconstruction Project.

He is member of Educational Committee of “Italian School of Breast Disease” and lecturer at the Master’s Degree Course of Mastology in Madrid, Spain.

Since the beginning of his career he contributed to develop new techniques such as radio guided sentinel lymph node biopsy, nipple sparing mastectomy with one step reconstruction, development of the radio occult lesion localization and partial breast irradiation with intraoperative radiation therapy technique.

He is a member of the editorial boards of various cancer publications and author with over 400 scientific citations.

 

ABSTRACT:

5 years robotic breast surgery experience from EIO, Milan

The technique of Robotic Nipple sparing Mastectomy was initially performed in 2014 and published at European Institute of Oncology describing the first 3 cases. The same research has continued evaluating feasibility, reproducibility and safety of the technique studying 29 consecutive procedures of robotic nipple sparing mastectomy and immediate robotic breast reconstruction. In these initial cases authors found two main advantages such as better vision and offering the patient a minimally invasive approach with an anatomically more respectful mastectomy. Considering the preliminary results, a randomized controlled trial comparing robotic nipple sparing mastectomy and classical open technique has been designed to compare the two techniques. Considering the recent community discussions regarding the oncological outcome, a retrospective analysis of all 94 procedures performed at March 2019 was completed to evaluate intermediate local relapse rate and overall survival rate. The available retrospective analysis results will be presented and discussed in this presentation.

Robotic nipple sparing mastectomy vs conventional nipple sparing mastectomy: a prospective RCT evaluating patients’ satisfaction.

The technique of Robotic Nipple sparing Mastectomy was initially published at European Institute of Oncology describing the first 3 cases. The same research has continued evaluating feasibility, reproducibility and safety of the technique  studying 29 consecutive procedures of robotic nipple sparing mastectomy and immediate robotic breast reconstruction [2]. In these initial cases authors found two main advantages such as better vision and offering the patient a minimally invasive approach with an anatomically more respectful mastectomy. Considering the preliminary results, a randomized controlled trial comparing robotic nipple sparing mastectomy and classical open technique has been designed to compare the two techniques. The aim of the study was to evaluate post-operative outcomes, satisfaction of the patients and long term oncological outcome. First available trial results will be presented and discussed.